289 related articles for article (PubMed ID: 34684819)
1. Inhibitory Role of Berberine, an Isoquinoline Alkaloid, on NLRP3 Inflammasome Activation for the Treatment of Inflammatory Diseases.
Sarbadhikary P; George BP; Abrahamse H
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684819
[TBL] [Abstract][Full Text] [Related]
2. Phytochemical inhibitors of the NLRP3 inflammasome for the treatment of inflammatory diseases.
Özenver N; Efferth T
Pharmacol Res; 2021 Aug; 170():105710. PubMed ID: 34089866
[TBL] [Abstract][Full Text] [Related]
3. Phytochemicals as Novel Therapeutic Strategies for NLRP3 Inflammasome-Related Neurological, Metabolic, and Inflammatory Diseases.
Pellegrini C; Fornai M; Antonioli L; Blandizzi C; Calderone V
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31200447
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Targeting of NLRP3 Inflammasomes by Natural Products and Pharmaceuticals: A Novel Mechanistic Approach for Inflammatory Diseases.
Jahan S; Kumar D; Chaturvedi S; Rashid M; Wahajuddin M; Khan YA; Goyal SN; Patil CR; Mohanraj R; Subramanya S; Ojha S
Curr Med Chem; 2017; 24(16):1645-1670. PubMed ID: 28245768
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the NEK7-licensed NLRP3 inflammasome activation: Mechanisms, role in diseases and related inhibitors.
Zhao N; Li CC; Di B; Xu LL
J Autoimmun; 2020 Sep; 113():102515. PubMed ID: 32703754
[TBL] [Abstract][Full Text] [Related]
6. Medicinal plants and bioactive natural products as inhibitors of NLRP3 inflammasome.
Bagherniya M; Khedmatgozar H; Fakheran O; Xu S; Johnston TP; Sahebkar A
Phytother Res; 2021 Sep; 35(9):4804-4833. PubMed ID: 33856730
[TBL] [Abstract][Full Text] [Related]
7. NLRP3 inflammasome inhibitor INF39 attenuated NLRP3 assembly in macrophages.
Shi Y; Lv Q; Zheng M; Sun H; Shi F
Int Immunopharmacol; 2021 Mar; 92():107358. PubMed ID: 33508701
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases.
Seok JK; Kang HC; Cho YY; Lee HS; Lee JY
Arch Pharm Res; 2021 Jan; 44(1):16-35. PubMed ID: 33534121
[TBL] [Abstract][Full Text] [Related]
9. Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome in Cardiovascular Disorders.
Wang Z; Hu W; Lu C; Ma Z; Jiang S; Gu C; Acuña-Castroviejo D; Yang Y
Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2765-2779. PubMed ID: 30571177
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of phytochemicals on NLRP3 inflammasome activation: A review.
Olcum M; Tastan B; Ercan I; Eltutan IB; Genc S
Phytomedicine; 2020 Aug; 75():153238. PubMed ID: 32507349
[TBL] [Abstract][Full Text] [Related]
11. Berberine suppresses influenza virus-triggered NLRP3 inflammasome activation in macrophages by inducing mitophagy and decreasing mitochondrial ROS.
Liu H; You L; Wu J; Zhao M; Guo R; Zhang H; Su R; Mao Q; Deng D; Hao Y
J Leukoc Biol; 2020 Jul; 108(1):253-266. PubMed ID: 32272506
[TBL] [Abstract][Full Text] [Related]
12. NLRP3 inflammasome as a key driver of vascular disease.
Takahashi M
Cardiovasc Res; 2022 Jan; 118(2):372-385. PubMed ID: 33483732
[TBL] [Abstract][Full Text] [Related]
13. Baicalin ameliorates atherosclerosis by inhibiting NLRP3 inflammasome in apolipoprotein E-deficient mice.
Zhao J; Wang Z; Yuan Z; Lv S; Su Q
Diab Vasc Dis Res; 2020; 17(6):1479164120977441. PubMed ID: 33269624
[TBL] [Abstract][Full Text] [Related]
14. Berberine inhibits palmitate-induced NLRP3 inflammasome activation by triggering autophagy in macrophages: A new mechanism linking berberine to insulin resistance improvement.
Zhou H; Feng L; Xu F; Sun Y; Ma Y; Zhang X; Liu H; Xu G; Wu X; Shen Y; Sun Y; Wu X; Xu Q
Biomed Pharmacother; 2017 May; 89():864-874. PubMed ID: 28282788
[TBL] [Abstract][Full Text] [Related]
15. The NLRP3 Inflammasome as a Pharmacological Target.
Marchetti C
J Cardiovasc Pharmacol; 2019 Oct; 74(4):285-296. PubMed ID: 31335445
[TBL] [Abstract][Full Text] [Related]
16. Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell.
Yao M; Fan X; Yuan B; Takagi N; Liu S; Han X; Ren J; Liu J
BMC Complement Altern Med; 2019 Aug; 19(1):216. PubMed ID: 31412862
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol inhibits the acetylated α-tubulin-mediated assembly of the NLRP3-inflammasome.
Misawa T; Saitoh T; Kozaki T; Park S; Takahama M; Akira S
Int Immunol; 2015 Sep; 27(9):425-34. PubMed ID: 25855661
[TBL] [Abstract][Full Text] [Related]
18. Current status of terpenoids as inflammasome inhibitors.
Hortelano S; González-Cofrade L; Cuadrado I; de Las Heras B
Biochem Pharmacol; 2020 Feb; 172():113739. PubMed ID: 31786260
[TBL] [Abstract][Full Text] [Related]
19. NLRP3 inflammasome as a target of berberine in experimental murine liver injury: interference with P2X7 signalling.
Vivoli E; Cappon A; Milani S; Piombanti B; Provenzano A; Novo E; Masi A; Navari N; Narducci R; Mannaioni G; Moneti G; Oliveira CP; Parola M; Marra F
Clin Sci (Lond); 2016 Oct; 130(20):1793-806. PubMed ID: 27439970
[TBL] [Abstract][Full Text] [Related]
20. Specific NLRP3 inflammasome inhibitors: promising therapeutic agents for inflammatory diseases.
Vong CT; Tseng HHL; Yao P; Yu H; Wang S; Zhong Z; Wang Y
Drug Discov Today; 2021 Jun; 26(6):1394-1408. PubMed ID: 33636340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
